Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoint Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Nociceptin receptor signaling and regulation of dopamine transmission in drug reward circuitry
Statistical Methods for Optimizing Personalized Treatment Selection
Stat3 in Epitherlial Carcinogenesis
Development of Methods to Improve Isolated Pancreatic Islet Function
Pyrrolo(1,4)Benzodiazepine Antitumor Antibiotics
Recently added grants:
Inflammatory microenvironment in brain metastasis
Understanding the Adoption and Impact of New Risk Assessment Technologies in Prostate Cancer Care
Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer
Pro-tumor functions of neutrophils in squamous cell lung cancer
Artificial Intelligence driven prediction of brain metastasis from primary tumor sites at diagnosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43309-8-0-1
Application #
7587179
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/ Fox Chase Cancer Center
$2,364,525
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
Clapper, Margie /
$1,632,611
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/
Comments
Be the first to comment on this grant